following an abbreviated submission
triamcinolone hexacetonide is accepted for use within NHS Scotland.
Indication under review: juvenile idiopathic arthritis (JIA).
This submission relates to a new licence extension for JIA where previously an unlicensed preparation has been used. This is the first intra-articular corticosteroid licensed for JIA.
Download detailed advice110KB (PDF)
- Medicine name:
- triamcinolone hexacetonide
- SMC ID:
- Juvenile idiopathic arthritis (JIA).
- Pharmaceutical company
- Intrapharm Laboratories Ltd
- BNF chapter
- Musculoskeletal and joint diseases
- Submission type
- Date advice published
- 09 November 2015